Literature DB >> 7160151

Application of the predictive value model in the analysis of test effectiveness.

R S Galen.   

Abstract

There are four levels at which laboratory tests and procedures can be evaluated relative to their effectiveness: 1. Analytical analysis of laboratory test: precision, accuracy, analytical sensitivity, and analytical specificity. 2. Diagnostic analysis of laboratory test: diagnostic sensitivity, diagnostic specificity, Youden index, likelihood ratio, and ROC curve. 3. Operational analysis of laboratory test: predictive value of positive result, predictive value of negative result, efficiency, discriminant function, and so forth. 4. Medical decision-making analysis of laboratory test: threshold probability, cost-benefit analysis, and solving the decision tree. Laboratory test selection can occur at any level, without knowledge of the test's evaluation and performance at the other levels. Alternatively, the development of new laboratory tests can proceed from level 1 to level 4, or vice versa. Unfortunately, the former is usually the case and most of the tests in use today have never been evaluated at the medical decision-making level. In evaluating clinical laboratory tests, it is essential that the laboratory have at its disposal simple ways to analyze sets of data. The predictive value model has proven to be effective in designing test strategies and evaluating the usefulness of laboratory tests. The widespread use of computers in laboratory medicine should permit this approach to data analysis to become routine in the next few years.

Mesh:

Substances:

Year:  1982        PMID: 7160151

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  10 in total

Review 1.  Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature.

Authors:  P A Hall; A J D'Ardenne
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

2.  Independent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy.

Authors:  Li Jun; Yan Zhenlin; Gong Renyan; Wang Yizhou; Wan Xuying; Xue Feng; Xia Yong; Wang Kui; Liu Jian; Wu Dong; Wang Hongyang; Shi Lehua; Wu Mengchao; Shen Feng
Journal:  Oncologist       Date:  2012-05-31

3.  The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma.

Authors:  M G Castagna; H P Tala Jury; C Cipri; V Belardini; C Fioravanti; L Pasqui; F Sestini; A Theodoropoulou; F Pacini
Journal:  J Endocrinol Invest       Date:  2011-03-07       Impact factor: 4.256

4.  Identification of an immunodominant 32-kilodalton membrane protein of Leishmania donovani infantum promastigotes suitable for specific diagnosis of Mediterranean visceral leishmaniasis.

Authors:  F Tebourski; A el Gaied; H Louzir; R Ben Ismail; R Kammoun; K Dellagi
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

5.  Evaluation of the Diagnostic Performance of EU-TIRADS in Discriminating Benign from Malignant Thyroid Nodules: A Prospective Study in One Referral Center.

Authors:  Roussanka D Kovatcheva; Alexander D Shinkov; Inna D Dimitrova; Ralitsa B Ivanova; Kalin N Vidinov; Radina S Ivanova
Journal:  Eur Thyroid J       Date:  2020-05-18

6.  Age-specific prostate specific antigen cutoffs for guiding biopsy decision in Chinese population.

Authors:  Rong Na; Yishuo Wu; Jianfeng Xu; Haowen Jiang; Qiang Ding
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

Review 7.  Circulating Phospholipids as Biomarkers of Breast Cancer: A Review.

Authors:  Dharmica April Haridatt Mistry; Peter William French
Journal:  Breast Cancer (Auckl)       Date:  2016-11-13

8.  Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.

Authors:  Guido J H Bastiaens; Alfred B Tiono; Joseph Okebe; Helmi E Pett; Sam A Coulibaly; Bronner P Gonçalves; Muna Affara; Alphonse Ouédraogo; Edith C Bougouma; Guillaume S Sanou; Issa Nébié; John Bradley; Kjerstin H W Lanke; Mikko Niemi; Sodiomon B Sirima; Umberto d'Alessandro; Teun Bousema; Chris Drakeley
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

9.  Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population.

Authors:  Yi-Shuo Wu; Xiao-Bo Wu; Ning Zhang; Guang-Liang Jiang; Yang Yu; Shi-Jun Tong; Hao-Wen Jiang; Shan-Hua Mao; Rong Na; Qiang Ding
Journal:  Asian J Androl       Date:  2018 Jul-Aug       Impact factor: 3.285

10.  Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors.

Authors:  Anna Rosa Garbuglia; Ubaldo Visco-Comandini; Raffaella Lionetti; Daniele Lapa; Filippo Castiglione; Gianpiero D'Offizi; Chiara Taibi; Marzia Montalbano; Maria Rosaria Capobianchi; Paola Paci
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.